1. Home
  2. ALLO vs ALCO Comparison

ALLO vs ALCO Comparison

Compare ALLO & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$40.82

Market Cap

267.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
ALCO
Founded
2017
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.9M
267.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALLO
ALCO
Price
$1.80
$40.82
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
$8.27
N/A
AVG Volume (30 Days)
6.3M
27.2K
Earning Date
03-12-2026
02-04-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$29,059,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$27.02
52 Week High
$3.78
$43.20

Technical Indicators

Market Signals
Indicator
ALLO
ALCO
Relative Strength Index (RSI) 58.49 58.23
Support Level $1.56 $40.60
Resistance Level $1.84 $41.66
Average True Range (ATR) 0.16 1.31
MACD -0.01 -0.18
Stochastic Oscillator 67.96 26.32

Price Performance

Historical Comparison
ALLO
ALCO

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: